Skip to main content

Table 2 Knowledge of guardians towards ICS therapy

From: Guardian’s knowledge and attitude towards inhaled corticosteroids aerosol therapy and medication compliance of children with wheezing diseases

Knowledge

Unaware

Moderately aware

Very aware

K1. Classification of wheezing diseases

192 (37.94)

284 (56.13)

30 (5.93)

K2. Etiology of wheezing diseases

204 (40.32)

274 (54.15)

28 (5.53)

K3. Clinical manifestations of wheezing diseases

159 (31.42)

307 (61.67)

40 (7.91)

K4. Medication for wheezing diseases

214 (42.29)

259 (51.19)

33 (6.52)

K6. Adverse effects of glucocorticoid therapy

235 (46.44)

237 (46.84)

34 (6.72)

K8. Classification of inhalation aerosol devices

157 (31.03)

299 (59.09)

50 (9.88)

K9. Correct operation of inhalation aerosol therapy

89 (17.59)

345 (68.18)

72 (14.23)

K11. You should clean the child’s mouth and wash his/her face before inhalation aerosol therapy and should not use oily face cream.

104 (20.55)

341 (67.39)

61 (12.06)

K12. Correct breathing mode before inhalation aerosol therapy

118 (23.32)

331 (65.42)

57 (11.26)

K13. You should observe the child’s complexion and breathing during the inhalation aerosol therapy.

74 (14.62)

359 (70.95)

73 (14.43)

K14. You should help your child to rinse his/her mouth for oral care and clean his/her face after inhalation aerosol therapy.

69 (13.64)

330 (65.22)

107 (21.15)

K15. You should help your child to cough and cough after inhalation aerosol therapy, e.g., turning and slapping his/her back.

84 (16.60)

331 (65.42)

91 (17.98)

K16. At the end of inhalation therapy, the inhalation aerosol device needs to be cleaned in time and dried for future use.

43 (8.50)

329 (65.02)

134 (26.48)

 

Correct rate

  

K5. Predisposing factors of wheezing diseases

137 (27.08)

  

K7. Adverse effects of ICS aerosol therapy

127 (25.10)

  

K10. Suitable position for ICS aerosol therapy in children

470 (92.89)